Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients

Detalles Bibliográficos
Autores principales: Lyski, Zoe L., Kim, Sunny, Lee, David Xthona, Sampson, David, Raué, Hans P., Raghunathan, Vikram, Ryan, Debbie, Brunton, Amanda E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/
https://www.ncbi.nlm.nih.gov/pubmed/34518841
http://dx.doi.org/10.1101/2021.09.02.21262146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/
https://www.ncbi.nlm.nih.gov/pubmed/34518841
http://dx.doi.org/10.1101/2021.09.02.21262146

Ejemplares similares